Study: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.full.pdf
"The main finding of this study was the cardiac adverse event (CAE) rates of 162/million and
94/million post- Pfizer-BioNTech BNT162b2 vaccination dose two for the 12-15- and 16–17-
year-old boys, respectively. Approximately 86% of these resulted in hospitalization for both age
groups."
"The main finding of this study was the cardiac adverse event (CAE) rates of 162/million and
94/million post- Pfizer-BioNTech BNT162b2 vaccination dose two for the 12-15- and 16–17-
year-old boys, respectively. Approximately 86% of these resulted in hospitalization for both age
groups."